Interventions in Hypertrophic Obstructive Cardiomyopathy.

Autor: Ding WY; Liverpool Heart and Chest Hospital, Liverpool, United Kingdom; Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, United Kingdom., Meah MN; Liverpool Heart and Chest Hospital, Liverpool, United Kingdom., Stables R; Liverpool Heart and Chest Hospital, Liverpool, United Kingdom., Cooper RM; Liverpool Heart and Chest Hospital, Liverpool, United Kingdom; Research Institute of Sports and Exercise Science, Liverpool John Moores University, Liverpool, United Kingdom. Electronic address: rob.cooper@lhch.nhs.uk.
Jazyk: angličtina
Zdroj: The Canadian journal of cardiology [Can J Cardiol] 2024 May; Vol. 40 (5), pp. 833-842. Date of Electronic Publication: 2023 Dec 08.
DOI: 10.1016/j.cjca.2023.12.001
Abstrakt: Obstructive hypertrophic cardiomyopathy is the most common genetically transmitted cardiomyopathy that is associated with significant morbidity and mortality. Despite contemporary treatments and interventions, the management of patients with obstructive hypertrophic cardiomyopathy remains poorly defined compared with other branches of cardiology. In this review, we discuss established and novel therapeutic interventions in patients with obstructive hypertrophic cardiomyopathy with a focus on percutaneous and surgical strategies including surgical myectomy, mitral valve repair or replacement, percutaneous alcohol septal ablation, pacemaker and cardioverter-defibrillator implantation, septal embolization, radiofrequency endocardial catheter ablation, and percutaneous intramyocardial septal radiofrequency ablation.
(Crown Copyright © 2023. Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: